NODTHERA LTD has a total of 43 patent applications. It increased the IP activity by 650.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are PUETTER MEDICE CHEM PHARM, BIOARDIS LLC and MIDIT.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Australia | 3 | |
#4 | Brazil | 3 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | United Kingdom | 3 | |
#8 | Israel | 3 | |
#9 | Republic of Korea | 3 | |
#10 | Singapore | 3 | |
#11 | United States | 3 | |
#12 | Taiwan | 2 | |
#13 | Argentina | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Harrison David | 32 |
#2 | Watt Alan Paul | 27 |
#3 | Bock Mark G | 23 |
#4 | Levenets Oleksandr | 17 |
#5 | Porter Roderick Alan | 10 |
#6 | Woyciechowski Jakub | 10 |
#7 | Galezowski Michal | 9 |
#8 | Kowalczyk Piotr | 8 |
#9 | Boutard Nicolas | 8 |
#10 | Topolnicki Grzegorz Witold | 7 |
Publication | Filing date | Title |
---|---|---|
WO2020249669A1 | Sulfonamide derivatives and uses thereof | |
WO2020249664A1 | Sulfonylurea derivatives and uses thereof | |
WO2020249667A1 | Sulfonylurea derivatives and uses thereof | |
WO2020157069A1 | Amino heterocyclic compounds and uses thereof | |
WO2020152361A1 | Carbamate derivatives and uses thereof | |
GB201721185D0 | Sulphonyl urea derivatives | |
GB201712282D0 | Selective inhibitors of NLRP3 inflammasome | |
GB201703979D0 | Chemical compounds | |
EP3272739A1 | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |